Literature DB >> 27919699

Identification of different shapes, colors and sizes of standard oral dosage forms in diabetes type 2 patients-A pilot study.

Sven Stegemann1, Regina Riedl2, Harald Sourij3.   

Abstract

The clear identification of drug products by the patients is essential for a safe and effective medication management. In order to understand the impact of shape, size and color on medication identification a study was performed in subjects with type 2 diabetes mellitus (T2D). Ten model drugs differentiated by shape, size and color were evaluated using a mixed method of medication schedule preparation by the participants followed by a semi-structured interview. Detection times were fastest for the large round tablet shape and the bi-chromatic forms. Larger size was easier to identify than the smaller sizes except for the bi-chromatic forms. The shape was the major source of errors, followed by the size and the color dimension. The results from this study suggests that color as a single dimension are perceived more effectively by subjects with T2D compared to shape and size, which requires a more demanding processing of three dimension and is dependent on the perspective.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug recognition; Drug safety; Effectiveness; Medication error; Medicine identification; Product differentiation

Mesh:

Substances:

Year:  2016        PMID: 27919699     DOI: 10.1016/j.ijpharm.2016.11.066

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings.

Authors:  Xinyu Zhao; Cecilia Milford; Jenni Smit; Bongiwe Zulu; Peter Boyd; R Karl Malcolm; Mags Beksinska
Journal:  AIDS Behav       Date:  2022-03-16

Review 2.  A systematic literature review of LASA error interventions.

Authors:  Rachel Bryan; Jeffrey K Aronson; Alison J Williams; Sue Jordan
Journal:  Br J Clin Pharmacol       Date:  2020-12-15       Impact factor: 3.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.